AR

Anil Rajauria

Active Director Director DIN 10114162
DIN 10114162 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Anil Rajauria

Data last updated:

Anil Rajauria is a Director at Risesun Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Risesun Pharmaceutical Private Limited reported revenue of ₹2.8 Lakh (FY 2025).

DIN 10114162
Primary Designation Director
Industry Pharma
First Appointment 12 Apr 2023
Oldest Company Age 3 yrs
Largest company Risesun Pharmaceutical Private Limited · ₹2.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Apr 20232023₹2.8 Lakh (FY 2025)Active

Board colleagues of Anil Rajauria

NameDINCompanyDesignation
Ravikant Litoria10114163Risesun Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Risesun Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anil Rajauria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Rajauria

Anil Rajauria currently holds 1 directorship: Risesun Pharmaceutical Private Limited (Director, since 12 Apr 2023, revenue ₹2.8 Lakh (FY 2025)).

Anil Rajauria was first appointed on 12 Apr 2023 as Director at Risesun Pharmaceutical Private Limited.

The current boards of Anil Rajauria's companies include Ravikant Litoria (Risesun Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available